We
have developed herein a quantitative mass spectrometry-based
approach to analyze the etiology-related alterations in fucosylation
degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular
carcinoma (HCC). The three most common etiologies, including infection
with hepatitis B virus (HBV), infection with hepatitis C virus (HCV),
and heavy alcohol consumption (ALC), were investigated. Only 10 μL
of serum was used in this assay in which haptoglobin was immunoprecipitated
using a monoclonal antibody. The N-glycans of haptoglobin
were released with PNGase F, desialylated, and permethylated prior
to MALDI-QIT-TOF MS analysis. In total, N-glycan
profiles derived from 104 individual patient samples were quantified
(14 healthy controls, 40 cirrhosis, and 50 HCCs). A unique pattern
of bifucosylated tetra-antennary glycan, with both core and antennary
fucosylation, was identified in HCC patients. Quantitative analysis
indicated that the increased fucosylation degree was highly associated
with HBV- and ALC-related HCC patients compared to that of the corresponding
cirrhosis patients. Notably, the bifucosylation degree was distinctly
increased in HCC patients versus that in cirrhosis of all etiologies.
The elevated bifucosylation degree of haptoglobin can discriminate
early stage HCC patients from cirrhosis in each etiologic category,
which may be used to provide a potential marker for early detection
and to predict HCC in patients with cirrhosis.